Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Fresenius Medical Care Ag ADR (NY: FMS )

19.29 -0.34 (-1.73%)
Official Closing Price Updated: 4:10 PM EDT, Jul 31, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Fresenius Medical Care Ag ADR

< Previous 1 2 3 Next >
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers 
Via Benzinga
Blue Chip Stocks In Focus: Fresenius Medical Care AG
Fresenius Medical Care is the world’s leading provider of products and services for individuals with renal (kidney) diseases in terms of revenues and number of patients treated. 
Via Talk Markets
Wego's Dialysis Business Seeks Hong Kong IPO in MedTech Boom
Key Takeaways: Weigao Blood Purification filed for a Hong Kong IPO soon after bringing in well-known institutional investors The company is a domestic leader in China’s... 
Via Benzinga
Inspira™ Technologies Strategically Plans to Actualize Hundreds of Millions in Conditional Distribution Agreements
Picture credit: Tim Goedhart on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice. 
Via Benzinga
Recap: Fresenius Medical Care Q1 Earnings
Fresenius Medical Care (NYSE:FMS) reported its Q1 earnings results on Wednesday, May 4, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 22, 2022
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is projected to report quarterly earnings at $0.13 per share on revenue of $439.63 million. • Sohu... 
Via Benzinga
How To Attend Fresenius Medical Care Q1 2022 Earnings Conference Call
Fresenius Medical Care (NYSE:FMS) will host a conference call at 09:30 AM ET on May 4, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga
Fresenius Medical Care's US Unit Announces $2.4B Three-Way Merger Agreement
Fresenius Medical Care AG & Co (NYSE: FMS) has agreed to merge its U.S. unit Fresenius Health Partners with medical services groups InterWell Health and Cricket Health... 
Via Benzinga
7 Stocks to Buy for the Coming Risk-On Rally
It can't hurt to consider these stocks to buy while investors wait for the Ukraine/Russia war to end 
Via InvestorPlace
Fresenius Medical Care: Q4 Earnings Insights
Fresenius Medical Care (NYSE:FMS) reported its Q4 earnings results on Tuesday, February 22, 2022 at 07:30 AM. Here's what investors need to know about the announcement... 
Via Benzinga
Fresenius's Q4 Operating Income Hit By COVID-19 Related Headwinds, Targets Earnings Growth In FY22
Fresenius Medical Care AG & Co's (NYSE: FMS) Q4 net income increased 29% Y/Y to €229 million, while quarterly net income was up 23% at constant currency.... 
Via Benzinga
Daily Report: Fresenius Medical Care (FMS)
If FMS's stock trades in the range of $30.00 to $40.00 this next year, its recent $34.41 share price might rise by $3.09 to reach $37.50 by February 10, 2023. 
Via Talk Markets
14 Stocks in the Healthcare Sector
Here are 14 companies in the Healthcare Sector that have investment-grade credit ratings of BBB- or better, cash flow yield of 6% or better, future total return of at least 5%. 
Via Talk Markets
GENERATION INCOME PROPERTIES CONTINUES TO ADD TO PORTFOLIO WITH CLOSING OF $3.1 MILLION CHICAGO ASSET
GENERATION INCOME PROPERTIES \nCONTINUES TO ADD TO PORTFOLIO WITH CLOSING OF $3.1 MILLION CHICAGO ASSET 
Via News Direct
Benzinga's Top Ratings Upgrades, Downgrades For November 11, 2021
Upgrades Barrington Research upgraded the previous rating for Clear Channel Outdoor Holdings Inc (NYSE: 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021
Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE: 
Via Benzinga
Fresenius Medical Care AG & Co KGaA (FMS) Q3 2021 Earnings Call Transcript
FMS earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Semiconductor Shortage Hits Supply Chain For MedTech Industry
According to a study commissioned by AdvaMed, the global semiconductor chip shortage is causing delays, order cancellations, and other supply disruptions at MedTech companies.... 
Via Benzinga
Ominous Death Cross Forms On Fresenius Medical Care's Chart
If history is any guide, there may be trouble ahead for shares of Fresenius Medical Care(NYSE:FMS). A so-called "death cross" has formed on its chart and, not... 
Via Benzinga
After NASDAQ Debut, Humacyte's Investor Adds $25M Infusion
Humacyte Inc (NASDAQ: HUMA), which merged with the special purpose acquisition company Alpha Healthcare Acquisition Corp last week, received an immediate... 
Via Benzinga
Fresenius Medical Care AG & Co KGaA (FMS) Q2 2021 Earnings Call Transcript
FMS earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Fresenius Medical Care Q2 Earnings
Shares of Fresenius Medical Care (NYSE:FMS) were unchanged after the company reported Q2 results. Quarterly Results Earnings per share were down 31.82% over the past year... 
Via Benzinga
15 European Dividend Aristocrats To Diversify Your Portfolio
In general, Dividend Aristocrats are the foundation for the portfolios of most serious dividend growth investors. European Dividend aristocrats are typically blue chip stocks that... 
Via Benzinga
Fresenius Medical Care A G & Co. (FMS) Q1 2021 Earnings Call Transcript
FMS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Earnings Scheduled For July 30, 2021
Companies Reporting Before The Bell • Lexicon Pharmaceuticals (NASDAQ:LXRX) is estimated to report earnings for its second quarter. • Embraer (NYSE:ERJ) is... 
Via Benzinga
< Previous 1 2 3 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.